PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 8563700-0 1995 Normalization of insulin resistance in non-obese essential hypertension by cilazapril treatment. Cilazapril 75-85 insulin Homo sapiens 17-24 11797459-0 2001 [Effect of cilazapril on insulin sensitivity in patients with essential arterial hypertension]. Cilazapril 11-21 insulin Homo sapiens 25-32 11797459-8 2001 After a 12-week cilazapril treatment insulin sensitivity significantly increased, while glucose efficacy was relatively unchanged. Cilazapril 16-26 insulin Homo sapiens 37-44 9240771-8 1996 Reduction of blood pressure with alpha blocker (bunazosin), ACE inhibitor (cilazapril), long-acting Ca++ blocker (amlodipine) significantly improved lowered insulin sensitivity. Cilazapril 75-85 insulin Homo sapiens 157-164 8674891-6 1996 Insulin resistance decreased by using antihypertensive treatments with bunazosin, cilazapril, amlodipine, and benidipine in hypertensive subjects. Cilazapril 82-92 insulin Homo sapiens 0-7 8563700-7 1995 Cilazapril treatment has beneficial effect in the reversal of insulin resistance in patients with essential hypertension. Cilazapril 0-10 insulin Homo sapiens 62-69 1388960-8 1992 Plasma glucose and insulin responses decreased by 8 +/- 3% (P less than .05) and 25 +/- 9% (P less than .002), respectively, in cilazapril-treated patients, but did not change in those treated with cilazapril plus HC. Cilazapril 128-138 insulin Homo sapiens 19-26 8628189-0 1995 [The effect of cilazapril and prazosin on insulin sensitivity in patients with essential hypertension]. Cilazapril 15-25 insulin Homo sapiens 42-49 8628189-2 1995 The objective of this study was to examine short-term effects of cilazapril and prazosin therapy on insulin sensitivity assessed by a 15" test of insulin tolerance of obese hypertensive persons. Cilazapril 65-75 insulin Homo sapiens 100-107